肌萎缩侧索硬化
肠-脑轴
肠道菌群
神经科学
微生物群
多发性硬化
疾病
肠道微生物群
神经退行性变
医学
生物
生物信息学
免疫学
病理
作者
Himanshi Yadav,Jaldhi,Rati Bhardwaj,Anamika Anamika,Amrita Bakshi,Suchi Gupta,Shashank Kumar Maurya
出处
期刊:Life Sciences
[Elsevier]
日期:2023-08-12
卷期号:330: 122022-122022
被引量:31
标识
DOI:10.1016/j.lfs.2023.122022
摘要
Emerging evidence have shown the importance of gut microbiota in regulating brain functions. The diverse molecular mechanisms involved in cross-talk between gut and brain provide insight into importance of this communication in maintenance of brain homeostasis. It has also been observed that disturbed gut microbiota contributes to neurological diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis and aging. Recently, gut microbiome-derived exosomes have also been reported to play an essential role in the development and progression of neurodegenerative diseases and could thereby act as a therapeutic target. Further, pharmacological interventions including antibiotics, prebiotics and probiotics can influence gut microbiome-mediated management of neurological diseases. However, extensive research is warranted to better comprehend this interconnection in maintenance of brain homeostasis and its implication in neurological diseases. Thus, the present review is aimed to provide a detailed understanding of gut-brain axis followed by possibilities to target the gut microbiome for improving neurological health.
科研通智能强力驱动
Strongly Powered by AbleSci AI